• Facial nerve monitoring i...
Price 10.50 €
• Cholesteatoma behind a no...
Price 10.50 €
• Correlation between laryn...
Price 10.50 €
• The neurotologic evaluati...
Price 10.50 €
• Vertigo: progress and pra...
Price 8.50 €
• Therapeutic choices for c...
Price 8.50 €
• Notes on voice and speech...
Price 8.50 €
• Migraine, neurone and ves...
Price 5.50 €
• Vocal forcing and posture...
Price 10.50 €
• Middle ear adenoma / carc...
Price 8.50 €
• Cervico facial lymphangio...
Price 10.50 €
• Treatment and rehabilitat...
Price 10.50 €
• Lateral fixation of the v...
Price 8.50 €
• Otogenic pneumocephalus: ...
Price 5.50 €
• Audiological comparison b...
Price 14.00 €
• Paediatric endoscopic sin...
Price 10.50 €
• Merkel cell carcinoma of ...
Price 8.50 €
• Metastatic melanoma to th...
Price 5.50 €
• A new look on septoplasti...
Price 10.50 €
• Clinical signs and correl...
Price 10.50 €
• Benign paroxysmal vertigo...
Price 8.50 €
• Congenital bilateral choa...
Price 5.50 €
• Early ENT manifestations ...
Price 10.50 €
• Contribution of clinical ...
Price 14.00 €
• How I do it: Salivary duc...
Price 8.50 €
• A simple assessment of qu...
Price 10.50 €
• Which face lift for which...
Price 14.00 €
• Pathophysiology of choles...
Price 10.50 €
• Clinical Practice Guideli...
Price 12.00 €
• Efficacy of voice therapy...
Price 10.50 €
• Development of an osteos...
Price 8.50 €
• Role of positron emission...
Price 15.00 €
• Prosody and reading: Temp...
Price 12.00 €
• Nasal cutaneous cryptococ...
Price 5.50 €
• Combined induction chemot...
Price 10.50 €
• Rhinitis and allergy test...
Price 8.50 €
• Balloon catheter dilatati...
Price 10.50 €
• Augmentation of the abdom...
Price 10.50 €
• Principes underlying the ...
Price 10.50 €
Total Order 382.50 €
|
2019
N#
1
|
2018
N#
1
|
2
|
3
|
4
|
5
|
2017
N#
1
|
2
|
3
|
4
|
5
|
2016
N#
1
|
2
|
3
|
4
|
5
|
2015
N#
1
|
2
|
3
|
4
|
5
|
2014
N#
1
|
2
|
3
|
4
|
5
|
2013
N#
1
|
2
|
3
|
4
|
5
|
2012
N#
1
|
2
|
3
|
4
|
5
|
2011
N#
1
|
2
|
3
|
4
|
5
|
2010
N#
1
|
2
|
3
|
4
|
5
|
2009
N#
1
|
2
|
3
|
4
|
5
|
2008
N#
1
|
2
|
3
|
4
|
5
|
2007
N#
1
|
2
|
3
|
4
|
5
|
2006
N#
1
|
2
|
3
|
4
|
5
|
2005
N#
|
1
|
2
|
3
|
4
|
5
|
2004
N#
1
|
2
|
3
|
4
|
5
|
2003
N#
1
|
2
|
3
|
4
|
5
|
2002
N#
1
|
2
|
3
|
4
|
5
|
2001
N#
1
|
2
|
3
|
4
|
5
|
2000
N#
|
1
|
2
|
3
|
4
|
5
|
1999
N#
1
|
2
|
3
|
4
|
5
|
1998
N#
1
|
2
|
3
|
5
|
1997
N#
1
|
2
|
3
|
4
|
5
|
1996
N#
4
|
5
|
Click on the number of the review to see the content
|
|
List of all teaching bulletins CME.
|
|
Editor reading committee.
|
|
Select of books and press articles.
|
|
If you wish to adjust the size of the displayed characters, click in
the high menu on "Your account" and choose the desired size.
|
|
Issue N# 3 - 2012
HEAD AND NECK
Parapharyngeal tumours: Management and postoperatory results analysis
Authors : Bourget K, Joubert M, Delemazure AS, Durand N, Espitalier F, Malard O. (Nantes)
Ref. : Rev Laryngol Otol Rhinol. 2012;133,3:129-136.
Article published in french 
Downloadable PDF document french
Summary :
Objectives: Parapharyngeal space tumours are rare and mostly benign, and their access is difficult. The aim of the study was to define the optimal treatment of these tumours. Material and methods: Clinical retrospective study, with histological, treatment, prognosis analysis of the parapharyngeal space tumours occurred between 1994 and 2012 and the surgical approach considerations. Results: 35 patients were included with a male sex ratio predominance (51,43%, p= ns). The mean age of diagnosis was 49 years. The majority of tumours were benign (75,76%, p< 0,001). 54,5% originated from salivary gland with a majority of pleomorphic adenomas (42,42%). The second most frequent aetiology found was schwannoma (21,21%). 2 patients refused the treatment. Accidentally discovered were frequent (28,57%). In the symptomatic forms, dysphagia dominated (25,71%). Oropharyngeal (20%) and/or cervical (17,14%) mass were rare. A CT scan and a MR imaging were performed in 82,86% and 71,43% of the cases. A fine needle aspiration cytology was achieved in 10 cases with a positive predictive value of 60%. The cervical submandibular trans digastric approach was the most accomplished (40%). Other approaches were also used: Trans oral (25,71%), parotidectomy (14,71%), combined trans oral and cervical or parotidectomy (14,71%) and the cervical approached associated to a mandibulotomy (5,71%). A complementary treatment was proposed in 85,7% of the cases of malignant tumours. Post-operative complications were dominated by Horner’s syndrome (n= 3), a temporary facial palsy (n= 5), definitive (n= 1), a velar insufficiency (n= 1), persistent pain (n= 6). Conclusions: The presence of 25% of malignant tumours and 40% of pleomorphic adenomas require removal of parapharyngeal tumours, even if non symptomatic.
Price : 10.50 €
|
|
|
|
